(Q36766480)

English

Histone deacetylase inhibitors--turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases

scientific article published on 22 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

Histone deacetylase inhibitors--turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

author name string

Daniel Riester

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Christian Hildmann

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Andreas Schwienhorst

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

language of work or name

0 references

publication date

22 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Applied Microbiology and Biotechnology

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

499-514

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

https://scigraph.springernature.com/pub.10.1007/s00253-007-0912-1

0 references

Role of histone deacetylases in acute leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-007-0912-1

21 January 2018

Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS00253-007-0912-1

21 January 2018

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00253-007-0912-1

21 January 2018

An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme

1 reference

https://api.crossref.org/works/10.1007%2FS00253-007-0912-1

21 January 2018

A histone deacetylase inhibitor enhances recombinant adeno-associated virus-mediated gene expression in tumor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00253-007-0912-1

21 January 2018

Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1124/MOL.105.016154

Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-06-0429

Identifiers

10.1007/S00253-007-0912-1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36766480&oldid=2041990868"